BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 29554658)

  • 21. Phosphotidylserine exposure and neutrophil extracellular traps enhance procoagulant activity in patients with inflammatory bowel disease.
    He Z; Si Y; Jiang T; Ma R; Zhang Y; Cao M; Li T; Yao Z; Zhao L; Fang S; Yu B; Dong Z; Thatte HS; Bi Y; Kou J; Yang S; Piao D; Hao L; Zhou J; Shi J
    Thromb Haemost; 2016 Apr; 115(4):738-51. PubMed ID: 26660948
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Inflammatory cytokines enhance procoagulant activity of platelets and endothelial cells through phosphatidylserine exposure in patients with essential hypertension.
    Li J; Tong D; Chen F; Song B; Wang Y; Liu Y; Zhang X; Liu N; Xu Y; Li Y; Yin X; Liu W
    J Thromb Thrombolysis; 2021 May; 51(4):933-940. PubMed ID: 33219895
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Phosphatidylserine-exposing blood cells, microparticles and neutrophil extracellular traps increase procoagulant activity in patients with pancreatic cancer.
    Yu M; Li T; Li B; Liu Y; Wang L; Zhang J; Jin J; Guan Y; Zuo N; Liu W; Jing H; Li Y; Du J; Dong Z; Jiang T; Xie R; Zhou J; Shi J
    Thromb Res; 2020 Apr; 188():5-16. PubMed ID: 32032826
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Contributions of phosphatidylserine-positive platelets and leukocytes and microparticles to hypercoagulable state in gastric cancer patients.
    Yang C; Ma R; Jiang T; Cao M; Zhao L; Bi Y; Kou J; Shi J; Zou X
    Tumour Biol; 2016 Jun; 37(6):7881-91. PubMed ID: 26700666
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Chemotherapy induces enhanced procoagulant activity through phosphatidylserine exposure in acute lymphoblastic leukemia.
    Dong X; Shi J; Zhou J; Chen X; Jin Y; Zhang X; Li X; Dai H; Wang J
    Thromb Res; 2013 Nov; 132(5):614-20. PubMed ID: 24074703
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Dissimilarity of increased phosphatidylserine-positive microparticles and associated coagulation activation in acute coronary syndromes.
    Liu Y; He Z; Zhang Y; Dong Z; Bi Y; Kou J; Zhou J; Shi J
    Coron Artery Dis; 2016 Aug; 27(5):365-75. PubMed ID: 27058313
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Increased Phosphatidylserine on Blood Cells in Oral Squamous Cell Carcinoma.
    Liu Y; Li B; Hu TL; Li T; Zhang Y; Zhang C; Yu M; Wang C; Hou L; Dong Z; Hu TS; Novakovic VA; Shi J
    J Dent Res; 2019 Jul; 98(7):763-771. PubMed ID: 30979345
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Homocysteine induces procoagulant activity of red blood cells via phosphatidylserine exposure and microparticles generation.
    Xie R; Jia D; Gao C; Zhou J; Sui H; Wei X; Zhang T; Han Y; Shi J; Bai Y
    Amino Acids; 2014 Aug; 46(8):1997-2004. PubMed ID: 24817414
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Platelet microparticles and vascular cells interactions: a checkpoint between the haemostatic and thrombotic responses.
    Morel O; Morel N; Freyssinet JM; Toti F
    Platelets; 2008 Feb; 19(1):9-23. PubMed ID: 18231934
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Phosphatidylserine-exposing blood and endothelial cells contribute to the hypercoagulable state in essential thrombocythemia patients.
    Tong D; Yu M; Guo L; Li T; Li J; Novakovic VA; Dong Z; Tian Y; Kou J; Bi Y; Wang J; Zhou J; Shi J
    Ann Hematol; 2018 Apr; 97(4):605-616. PubMed ID: 29332224
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Lactadherin and procoagulant activities of red blood cells in cyclosporine induced thrombosis.
    Zheng YN; Yu HJ; Hou JX; Lu CF; Zhou J
    Chin Med J (Engl); 2009 Jul; 122(14):1674-80. PubMed ID: 19719970
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Interactions between neutrophil extracellular traps and activated platelets enhance procoagulant activity in acute stroke patients with ICA occlusion.
    Zhou P; Li T; Jin J; Liu Y; Li B; Sun Q; Tian J; Zhao H; Liu Z; Ma S; Zhang S; Novakovic VA; Shi J; Hu S
    EBioMedicine; 2020 Mar; 53():102671. PubMed ID: 32114386
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Procoagulant role of microparticles in routine storage of packed red blood cells: potential risk for prothrombotic post-transfusion complications.
    Aung HH; Tung JP; Dean MM; Flower RL; Pecheniuk NM
    Pathology; 2017 Jan; 49(1):62-69. PubMed ID: 27899173
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Hyperuricemia enhances procoagulant activity of vascular endothelial cells through TMEM16F regulated phosphatidylserine exposure and microparticle release.
    Yu H; Wang Z; Li Z; An Y; Yan M; Ji S; Xu M; Wang L; Dong W; Shi J; Gao C
    FASEB J; 2021 Sep; 35(9):e21808. PubMed ID: 34390515
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Phosphatidylserine-mediated platelet clearance by endothelium decreases platelet aggregates and procoagulant activity in sepsis.
    Ma R; Xie R; Yu C; Si Y; Wu X; Zhao L; Yao Z; Fang S; Chen H; Novakovic V; Gao C; Kou J; Bi Y; Thatte HS; Yu B; Yang S; Zhou J; Shi J
    Sci Rep; 2017 Jul; 7(1):4978. PubMed ID: 28694452
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Phosphatidylserine-exposing tumor-derived microparticles exacerbate coagulation and cancer cell transendothelial migration in triple-negative breast cancer.
    Zhang C; Yang Z; Zhou P; Yu M; Li B; Liu Y; Jin J; Liu W; Jing H; Du J; Tian J; Zhao Z; Wang J; Chu Y; Zhang C; Novakovic VA; Shi J; Wu C
    Theranostics; 2021; 11(13):6445-6460. PubMed ID: 33995667
    [No Abstract]   [Full Text] [Related]  

  • 37. [Expression and procoagulant activity of phosphatidylserine on the normal blood cells].
    Liu SC; Zhou J; Shi JL; Su YH
    Zhonghua Xue Ye Xue Za Zhi; 2011 Dec; 32(12):858-62. PubMed ID: 22339962
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Enhanced procoagulant activity of platelets after chemotherapy in non-small cell lung cancer.
    Ma R; Bi Y; Kou J; Zhou J; Shi J
    Cancer Biol Ther; 2017 Aug; 18(8):627-634. PubMed ID: 28718695
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Involvement of microparticles in diabetic vascular complications.
    Tsimerman G; Roguin A; Bachar A; Melamed E; Brenner B; Aharon A
    Thromb Haemost; 2011 Aug; 106(2):310-21. PubMed ID: 21713319
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Anthracycline treatment of the human monocytic leukemia cell line THP-1 increases phosphatidylserine exposure and tissue factor activity.
    Boles JC; Williams JC; Hollingsworth RM; Wang JG; Glover SL; Owens AP; Barcel DA; Kasthuri RS; Key NS; Mackman N
    Thromb Res; 2012 Feb; 129(2):197-203. PubMed ID: 21762960
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.